IRCT20081019001369N4RecruitingPhase 2
Clinical trial of minocycline against COVID-19
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Recruiting
- Enrollment
- 40
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 65 years (—)
- Sex
- All
Inclusion Criteria
- •Patients with covid-19 symptoms Indication of home quarantine and outpatient medication;
- •Age range 18 to 65
Exclusion Criteria
- •Patients connected to a catheter
- •Patients under chemotherapy
- •Patients taking cytotoxic drugs or corticosteroids
- •Pregnant and lactating patients
- •Patients with severe renal insufficiency
- •Patients with liver failure
- •Diabetic patients
Investigators
Similar Trials
Active, not recruiting
Phase 1
A randomized trial administering Minocycline, Acetylsalicylic acid or Pramipexole vs Placebo as add-on to antipsychotics in patients with schizophrenia or schizoaffecive disorder - MAP-S-01schizophrenia or schizoaffecive disorderEUCTR2010-023982-23-ROThe Stanley Medical Research Institute400
Active, not recruiting
Phase 1
Treatments of COVID-19 in primary care in the NetherlandsPatients with symptomatic COVID-19 in the community and in primary care, who are at higher risk of a complicated illness course.MedDRA version: 23.0Level: PTClassification code: 10084268Term: COVID-19 Class: 100000004862CTIS2022-501559-99-00Maastricht University682
Recruiting
Phase 2
Effect of berberine on COVID-19Covid-19.COVID-19 DiseaseU07.1IRCT20081019001369N2Mashhad University of Medical Sciences40
Active, not recruiting
Phase 1
A Pilot Study for the Evaluation of Minocycline in the Treatment of Central Retinal Vein OcclusionsCentral Retinal Vein OcclusionEUCTR2017-001143-12-GBThe National Eye Institute20
Active, not recruiting
Phase 1
A Pilot Study for the Evaluation of Minocycline in the Treatment of Branch Retinal Vein OcclusionsBranch Retinal Vein OcclusionEUCTR2017-001179-21-GBThe National Eye Institute20